Product
Piperacillin + Tazobactam + Temocillin
1 clinical trial
2 indications
Indication
SepsisIndication
Septic shockClinical trial
Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care UnitStatus: Recruiting, Estimated PCD: 2026-04-01